Buscar resultados de ensayos clínicos
Neurofibroma - 181 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: Sorafenib to Treat Children and Young Adults With Neurofibromatosis Type 1 and Inoperable Plexiform Neurofibromas Condición:
Fecha: 2008-07-31 Intervenciones:
|
Recruiting |
Nombre del estudio: Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Plexiform Neurofibromas That Cannot Be Removed by Surgery Condición:
Fecha: 2015-04-02 Intervenciones:
|
Recruiting |
Nombre del estudio: Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (PNs) Condición:
Fecha: 2015-09-05 |
Suspended |
Nombre del estudio: Study of Sutent®/Sunitinib (SU11248) in Subjects With NF-1 Plexiform Neurofibromas Condición:
|
Recruiting |
Nombre del estudio: Acceptance and Commitment Training for Adolescents and Young Adults With Neurofibromatosis Type 1, Plexiform Neurofibromas, and Chronic Pain Condición:
Fecha: 2015-06-12 Intervenciones: Other: Acceptance and Commitment Therapy (ACT) Acceptance and Commitment Therapy (ACT), a newer generati |
Active, not recruiting |
Nombre del estudio: Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 (16 Years +) Condición:
|
Completed |
Nombre del estudio: Use of RAD001 as Monotherapy in the Treatment of Neurofibromatosis 1 Related Internal Plexiform Neurofibromas Condición:
Intervenciones: Drug: RAD001: Everolimus 10 mg of RAD001 will be self-administered orally once daily continuously for on |
Completed |
Nombre del estudio: Study of Plexiform Neurofibromas in Neurofibromatosis Type 1 Condición:
Fecha: 2000-11-03 |
Recruiting |
Nombre del estudio: PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) Condición:
|
Completed |
Nombre del estudio: Study of Tasigna®/Nilotinib (AMN107) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas Condición:
Fecha: 2011-01-11 Intervenciones: Drug: Tasigna Following enrollment each subject will initially receive Tasigna orally at 200 mg twice da |